Moreover, MMP12 has also been found to be involved in increasing CD44+ PCa cells (prostate cancer stem-like cells (PCSLC) associated with chemoresistance), leading to the overexpression of aromatase and increased intracellular E2 in CRPC [43]. The gene discussed is CYP19A1; the disease is posterior cortical atrophy.